Karina A. Top

2.3k total citations
76 papers, 855 citations indexed

About

Karina A. Top is a scholar working on Epidemiology, Health and Infectious Diseases. According to data from OpenAlex, Karina A. Top has authored 76 papers receiving a total of 855 indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Epidemiology, 34 papers in Health and 31 papers in Infectious Diseases. Recurrent topics in Karina A. Top's work include Vaccine Coverage and Hesitancy (34 papers), Influenza Virus Research Studies (23 papers) and SARS-CoV-2 and COVID-19 Research (19 papers). Karina A. Top is often cited by papers focused on Vaccine Coverage and Hesitancy (34 papers), Influenza Virus Research Studies (23 papers) and SARS-CoV-2 and COVID-19 Research (19 papers). Karina A. Top collaborates with scholars based in Canada, United States and Switzerland. Karina A. Top's co-authors include Gaston De Serres, Scott A. Halperin, Julie A. Bettinger, Rebecca E. Chandler, Flor M. Muñoz, Noni E. MacDonald, Anne Pham‐Huy, Manish Sadarangani, Wendy Vaudry and Nicholas Wood and has published in prestigious journals such as The Lancet, JAMA and SHILAP Revista de lepidopterología.

In The Last Decade

Karina A. Top

69 papers receiving 834 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Karina A. Top Canada 16 352 260 241 220 136 76 855
Kristin Goddard United States 16 563 1.6× 314 1.2× 354 1.5× 184 0.8× 141 1.0× 50 1.2k
Laure F. Pittet Switzerland 15 323 0.9× 158 0.6× 384 1.6× 83 0.4× 63 0.5× 69 997
Muki Shey South Africa 17 453 1.3× 121 0.5× 358 1.5× 162 0.7× 82 0.6× 55 948
Anne M. Hause United States 21 768 2.2× 363 1.4× 275 1.1× 187 0.8× 159 1.2× 34 1.1k
Paige Marquez United States 23 1.1k 3.1× 630 2.4× 298 1.2× 431 2.0× 76 0.6× 58 1.8k
Maurizio Maccato United States 14 117 0.3× 200 0.8× 529 2.2× 217 1.0× 135 1.0× 33 958
Dianne Egli-Gany Switzerland 14 469 1.3× 50 0.2× 240 1.0× 153 0.7× 80 0.6× 16 1.1k
Amy Blain United States 16 340 1.0× 337 1.3× 559 2.3× 99 0.5× 62 0.5× 33 1.1k
Ulrikka Nygaard Denmark 18 316 0.9× 41 0.2× 245 1.0× 240 1.1× 221 1.6× 84 1.1k
Amadea Britton United States 15 968 2.8× 444 1.7× 569 2.4× 49 0.2× 41 0.3× 23 1.5k

Countries citing papers authored by Karina A. Top

Since Specialization
Citations

This map shows the geographic impact of Karina A. Top's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karina A. Top with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karina A. Top more than expected).

Fields of papers citing papers by Karina A. Top

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karina A. Top. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karina A. Top. The network helps show where Karina A. Top may publish in the future.

Co-authorship network of co-authors of Karina A. Top

This figure shows the co-authorship network connecting the top 25 collaborators of Karina A. Top. A scholar is included among the top collaborators of Karina A. Top based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karina A. Top. Karina A. Top is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Top, Karina A., Julie A. Bettinger, Joanne E. Embree, et al.. (2025). Active Surveillance for Myocarditis and Pericarditis in Canadian Children from 2021 to 2022: A Canadian Immunization Monitoring Program ACTive Study. The Journal of Pediatrics. 284. 114642–114642. 1 indexed citations
2.
Reed, Nicholas S., Carmen C. Brewer, Patricia Fast, et al.. (2024). Report of a SPEAC webinar 22 september 2023: Sensorineural hearing loss, lassa virus disease and vaccines. Vaccine. 43(Pt 1). 126525–126525. 1 indexed citations
3.
Wong, Hubert, Monika Naus, Matthew Muller, et al.. (2024). mRNA COVID-19 vaccine safety among older adults from the Canadian National Vaccine Safety Network. Vaccine. 42(18). 3819–3829. 2 indexed citations
4.
Top, Karina A., et al.. (2023). COVID-19 vaccination in pregnancy: How discrepant public health discourses shape responsibility for fetal health. SHILAP Revista de lepidopterología. 3. 100265–100265. 4 indexed citations
5.
Pham‐Huy, Anne, Jeffrey M. Pernica, François D. Boucher, et al.. (2023). Factors associated with intention for revaccination among patients with adverse events following immunization. Vaccine. 41(42). 6239–6247. 1 indexed citations
6.
Schober, Tilmann, Shaun K. Morris, Julie A. Bettinger, et al.. (2023). Outcomes of immunocompromised children hospitalized for Influenza, 2010-2021, the Canadian Immunization Monitoring Program Active (IMPACT). Clinical Microbiology and Infection. 29(7). 924–932. 4 indexed citations
7.
Burton, Catherine, Tom Blydt‐Hansen, Shaun K. Morris, et al.. (2023). Parent and healthcare provider views of live varicella vaccination of pediatric solid organ transplant recipients. Pediatric Transplantation. 27(8). e14609–e14609. 1 indexed citations
8.
Βaylis, Françoise, et al.. (2022). Prioritise research on vaccines for pregnant and breastfeeding women. The Lancet. 399(10328). 890–893. 9 indexed citations
9.
Top, Karina A., Robert T. Chen, Ofer Levy, et al.. (2022). Advancing the Science of Vaccine Safety During the Coronavirus Disease 2019 (COVID-19) Pandemic and Beyond: Launching an International Network of Special Immunization Services. Clinical Infectious Diseases. 75(Supplement_1). S11–S17. 12 indexed citations
10.
Top, Karina A., et al.. (2022). Deferring Risk: Limitations to the Evidence in Product Labels for Vaccine Use in Pregnancy. Journal of Women s Health. 31(8). 1103–1112. 3 indexed citations
11.
Bettinger, Julie A., Manish Sadarangani, Gaston De Serres, et al.. (2022). The Canadian National Vaccine Safety Network: surveillance of adverse events following immunisation among individuals immunised with the COVID-19 vaccine, a cohort study in Canada. BMJ Open. 12(1). e051254–e051254. 18 indexed citations
12.
Kochhar, Sonali, Ève Dubé, Janice Graham, et al.. (2021). COVID-19 vaccine safety questions and answers for healthcare providers (CONSIDER). Vaccine. 39(18). 2504–2505. 1 indexed citations
13.
Righolt, Christiaan H., Jessy Donelle, Paula Brna, et al.. (2021). Vaccine coverage among children with epilepsy in two Canadian provinces: A Canadian immunization research network study. Vaccine. 39(15). 2117–2123. 3 indexed citations
14.
Vogel, Tiphanie P., Karina A. Top, Christos Karatzios, et al.. (2021). Multisystem inflammatory syndrome in children and adults (MIS-C/A): Case definition & guidelines for data collection, analysis, and presentation of immunization safety data. Vaccine. 39(22). 3037–3049. 132 indexed citations
15.
McClymont, Elisabeth, Jason Brophy, Vinita Dubey, et al.. (2021). Is ‘conflict of interest’ a Misnomer? Managing interests in immunization research and evaluation. Human Vaccines & Immunotherapeutics. 18(1). 1879580–1879580. 1 indexed citations
16.
Graham, Janice, et al.. (2021). Healthcare providers’ interpretations of product labelling information developed through a consensus stakeholder approach. Vaccine. 39(19). 2652–2659. 4 indexed citations
17.
18.
19.
Top, Karina A., Kristine Macartney, Julie A. Bettinger, et al.. (2020). Active surveillance of acute paediatric hospitalisations demonstrates the impact of vaccination programmes and informs vaccine policy in Canada and Australia. Eurosurveillance. 25(25). 10 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kristin Goddard Breakdown of academic impact, for papers by Laure F. Pittet Breakdown of academic impact, for papers by Muki Shey Breakdown of academic impact, for papers by Anne M. Hause Breakdown of academic impact, for papers by Paige Marquez Breakdown of academic impact, for papers by Maurizio Maccato Breakdown of academic impact, for papers by Dianne Egli-Gany Breakdown of academic impact, for papers by Amy Blain Breakdown of academic impact, for papers by Ulrikka Nygaard Breakdown of academic impact, for papers by Amadea Britton
Rankless by CCL
2026